Free Trial

Tyra Biosciences (TYRA) SEC Filings & 10K Form

Tyra Biosciences logo
$9.34 -0.25 (-2.61%)
As of 12:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Tyra Biosciences SEC Filings

DateFilerForm TypeView
05/18/2025
11:15 PM
Tyra Biosciences (Filer)
Form EFFECT
05/14/2025
10:47 AM
JANUS HENDERSON GROUP PLC (Filed by)
Tyra Biosciences (Subject)
Form SCHEDULE 13G
05/12/2025
9:43 AM
FMR LLC (Filed by)
Tyra Biosciences (Subject)
Form SCHEDULE 13G/A
05/08/2025
3:30 PM
Tyra Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/31/2025
3:54 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SCHEDULE 13D/A
03/18/2025
5:44 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:44 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
5:02 PM
TCG Crossover GP I, LLC (Filed by)
Tyra Biosciences (Subject)
Form SCHEDULE 13G
02/07/2025
3:43 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
4:42 PM
Canaan XI L.P. (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
3:41 PM
Canaan 2020+ Co-Investment L.P. Series 7 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
4:09 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:00 PM
Subramony Siddarth (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
4:47 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:42 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
8:30 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
12/05/2024
3:21 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
6:06 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:47 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:31 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
11/14/2024
4:52 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:47 PM
NEXTECH VI ONCOLOGY SCSP (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/14/2024
3:34 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/13/2024
5:04 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/08/2024
3:43 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:24 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
5:18 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:22 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
4:15 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
6:00 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:01 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:15 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/22/2024
7:47 PM
Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2024
7:49 PM
Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
4:11 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/22/2024
4:13 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
4:04 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:23 PM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:12 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
4:51 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
10/15/2024
8:59 PM
Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/15/2024
6:22 PM
Boxer Asset Management Inc. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/02/2024
4:38 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
5:44 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
5:24 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:49 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:42 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:56 PM
Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:59 PM
Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:05 PM
Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:27 PM
Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2024
4:12 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:15 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:49 PM
Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2024
3:53 PM
Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:50 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:55 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:18 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:10 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
2:08 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
5:26 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Simson Jake (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TYRA) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners